TEHRAN UNIVERSITY OF MEDICAL SCIENCES
๐ฎ๐ทIran
- Country
- ๐ฎ๐ทIran
- Ownership
- Private
- Established
- 1934-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.tums.ac.ir
Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients
Phase 2
- Conditions
- COVID-19 VaccinesImmune System ToleranceHematopoietic Stem Cell Transplantation (HSCT)
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 100
- Registration Number
- NCT05185817
- Locations
- ๐ฎ๐ท
Hematology, Oncology, and Stem Cell Transplantation Research Center of shariaty Hospital, Tehran, Iran, Islamic Republic of
The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer
Completed
- Conditions
- Peritoneal MetastasesGastric CancerCOVID-19 Pandemic
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2021-12-23
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT05130710
- Locations
- ๐ฎ๐ท
Cancer institute, Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of
Peri-implant Tissue Stability Following Tissue Augmentation Harvested From Deep Palate or Tuberosity
Not Applicable
- Conditions
- Alveolar Ridge AugmentationTissue DonorsTissue Transplantation
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2021-08-20
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 34
- Registration Number
- NCT05014763
- Locations
- ๐ฎ๐ท
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
Peri-Implant Soft and Hard Tissue Stability Following Socket Preservation
Not Applicable
Completed
- Conditions
- Bone TransplantationAlveolar Ridge Augmentation
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2021-08-13
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 48
- Registration Number
- NCT05005377
Tele-Physiotherapy After COVID-19 Hospitalization
Not Applicable
Completed
- Conditions
- Covid19Coronavirus Disease 2019
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2022-06-03
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 72
- Registration Number
- NCT04895371
- Locations
- ๐ฎ๐ท
Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of
Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer
Phase 2
Recruiting
- Conditions
- Cervix Uteri Cancer
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2021-10-12
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT04831437
- Locations
- ๐ฎ๐ท
Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of
The Benefit of Surgery in Stage IV of Breast Cancer
Not Applicable
- Conditions
- Breast Cancer Stage IV
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2021-01-06
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 212
- Registration Number
- NCT04697043
- Locations
- ๐ฎ๐ท
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
Cigarette Smoking in Non-alcoholic Steatohepatitis
Not Applicable
Completed
- Conditions
- Non-Alcoholic Fatty Liver Disease
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 104
- Registration Number
- NCT04688307
- Locations
- ๐ฎ๐ท
Gastroenterology clinic, Sina hospital., Tehran, Iran, Islamic Republic of
๐ฎ๐ทSina Hospital, TUMS, Tehran, Iran, Islamic Republic of
Comparison of Lidocaine-Prilocaine Combination and Vapocoolant for IV Cannulation Pain in the ED
Phase 3
Completed
- Conditions
- Pain
- Interventions
- Drug: Lidocaine-Prilocaine creamDrug: Vapocoolant spray
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 77
- Registration Number
- NCT04473820
- Locations
- ๐ฎ๐ท
IKCH, Tehran, Iran, Islamic Republic of
Oral 25-hydroxyvitamin D3 and COVID-19
Phase 2
- Conditions
- COVID 19
- Interventions
- Drug: Oral 25-Hydroxyvitamin D3
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-06-12
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 1500
- Registration Number
- NCT04386850
- Locations
- ๐ฎ๐ท
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of